Skip to content
Delayed ~15 min

PCRX PACIRA BIOSCIENCES

Permanent stock page ↗

Health Care · Russell 2000

Next earnings: not announced yet

What 10 analyst firms say about PACIRA BIOSCIENCES: their latest ratings, price targets and how far the stock is from them. How it works

36.43 USD+0.01 (+0.03%) today
Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

−7.0%to the avg target 33.88 USD−2.56 USD
Buy 1 · Hold 8 · Sell 1

10 rated views · 11 analyst/firm records · 10 firms

Latest report9 Oct 2026avg report date 6 Oct
Target rangeLowest to highest analyst target, not a forecast

Radar score

  • Russell 2000 · Top Picks · 6MNot scored · Average target is not above the current price
  • Russell 2000 · Safest consensus · 6MNot scored · Average target is not above the current price

Recent analyst activity · last 90 days

Our tracked history has 13 reports on PCRX from 11 analyst firms in the last 90 days (11 firms in the past year).

Comparing each firm's latest target with its previous one: 2 raised their price target, 1 lowered it, 1 left it unchanged and 4 have their first observed target in the past year.

Ratings, latest available report against the previous one: 0 upgrades and 3 downgrades.

Latest observed target change: HC Wainwright lowered its target from $38.00 (set 1 Jul 2026) to $36.50 on 9 Oct 2026.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
H.C. WainwrightDouglas TsaoHold9 Oct 202636.50 USD
JefferiesDennis DingHold8 Oct 202636.00 USD
JefferiesGlen SantangeloHold8 Oct 202636.00 USD
JPMorganHardik ParikhHold8 Oct 202636.50 USD
Leerink PartnersDaniel ClarkHold9 Sep 2026Conflicting reports · excluded
NeedhamSerge BelangerHold8 Oct 2026—
OppenheimerLes SulewskiBuy23 Sep 202632.00 USD
RBC Capital MarketsDouglas MiehmHold9 Oct 202636.50 USD
TruistAnish NikhanjHold9 Oct 202636.50 USD
Weiss RatingsUnnamed analyst—8 Oct 2026—
Data feed RESEARCHResearch TeamSell5 Oct 202621.00 USD

Partial coverage · checked 6 Nov (6 Nov 2026, 06:10 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.